HYDERABAD, India – February 29, 2024 – Medtronic, the global leader in medical technology, today inaugurated its newly expanded state-of-the-art Medtronic Engineering and Innovation Center (MEIC) in Hyderabad. The center was inauguratedearlier today by Shri D. Sridhar Babu, Honorable Minister of IT, Industries & Commerce, Govt. of Telangana, along with Geoff Martha, Chairman and CEO, Medtronic in the presence of Guest of Honor, Jennifer Larson, US Consul General. The R&D center’s expansion strategically aligns with Medtronic’s objective to expand its global R&D footprint and invest in the local innovation ecosystem. The expansion is part of the investment of approximately INR 3000cr (more than $350M) announced by Medtronic over a five-year period to scale up and expand the R&D facility and to employ 1500 people in future.
MEIC is also Medtronic’s largest R&D center outside the US.At 250,000 sq. ft. of total space, MEIC is going to focus on collaborative innovation, training and education, immersive experiences from the expanded space, all aimed towards shaping the future of healthcare technology. The new space will house aDigital Therapy & Innovation Lab, Connected Care Lab, Platform & Tech Lab, Systems Engineering Lab, Software Lab, as well as new workstations and wellness amenities for employees.
Speaking at the inauguration event, Honorable Minister for IT, Industries and Commerce, Government of Telangana, Sri D Sridhar Babu said, “The presence of MEIC in Hyderabad is a testament to Hyderabad emerging as a hotspot for medtech innovation. The State Government is fully committed to fostering this growing culture of innovation in the state and will work towards marking Hyderabad on a global map as an ideal destination for both medical devices manufacturing and research & development. We are equally thrilled to support Medtronic’s growth and look forward to their contributions in the state and country in healthcare innovation.”
Geoff Martha, Chairman and CEO, Medtronic said, “Innovation is at the core of every life transforming technology developed at Medtronic. Our R&D team in India plays a pivotal role in Medtronic’s global product development and MEIC‘s expansion marks a significant milestone in strengthening our global R&D capabilities. We thank the Government of Telangana for building a thriving local innovation ecosystem.There is significant headroom for innovation and growth todayand the future of healthcare technology rests on robust R&D.”
Divya Prakash Joshi, Vice President & Site Leader, MEIC,said, “MEIC currently supports many global business units of Medtronic to provide software engineering solutions and other engineering expertise in the areas of embedded and enterprise software, product security, data engineering, systems engineering, mechanical and hardware design, and quality & regulatory. This expansion will help drive our commitment to impact more patient lives globally and advance the healthcare technology industry. I thank the Government of Telangana for their continued support to us in shaping the future of healthcare technology.”
Senior leaders from Medtronic who joined Geoff and the Honorable Minister, Shri D. Sridhar Babu during the auspicious occasion were Mani Prakash, Vice President, Enterprise R&D;Feng Dong, Vice President Asia RLM and Divya Prakash Joshi, Vice President & Site Leader, MEIC. Jennifer Larson, US Consul General, and Shakthi M Nagappan, CEO, Telangana Lifesciences, Government of Telangana, were also present.
For over a decade, MEIC has contributed to excellence in global healthcare from its premises in Hyderabad, India. Since 2011, the dedicated team of engineers at the center has put innovative ideas to work to generate real solutions for real people. With 900+ engineers, MEIC is home to some of the best STEM talent bringing in diverse perspectives, and ambition to engineer the extraordinary. Beyond its technical prowess, MEIC collaborates closely with the Medtronic commercial team in India, fostering strategic and long-term partnerships with key opinion leaders, academic institutions, and hospital networks across the country. This collaborative approach underscores center’s commitment to playing a vital role in the broader healthcare ecosystem.
About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgicalrobotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE:MDT), visit www.Medtronic.com and follow @Medtronic on Twitter and LinkedIn.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
